Le Lézard
Classified in: Health, Business
Subjects: FNC, MAT

Pierre Corp. Secures $2.5 Million Equity Line Financing


WEST HOLLYWOOD, California, Jan. 3, 2020 /PRNewswire/ -- Pierre Corp. (OTCQB: PIRE), a consumer packaged goods contender with first phase focus on CBD beverages, prepares to strengthen its position in the marketplace with resources made available through a $2.5 Million Equity line Financing with Tiger Trout Capital LLC. The terms of the Equity Agreement will give Pierre Corp the right, but never the obligation, to sell to Tiger Trout up to 2.5 Million Dollars worth of Pierre's registered common stock over an anticipated two-year period at times and in amounts that Pierre deems appropriate. Pierre Corp products are slated to be made available through wholesale, retail and end user e-commerce sales channels in the first quarter of 2020.

The company plans to access the capital for its ongoing development, inventory and marketing programs. For more information please visit our website; www.pierrecorp.com.

As the target market becomes increasingly educated, a growing demand for healthier, higher quality selections position the Company to become a considerable disruptor in the industry. Pierre is bringing healthier options to market as consumers seek health conscious alternatives to popular sugary, sweet and generally unhealthy carbonated beverages.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state.

Safe Harbor Statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer demands;; seasonal nature of our business. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this press release, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements. 

The OTC Markets or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management. 

Contact
Tel: +1-818-855-8199
Email: [email protected]

SOURCE Pierre Corp.


These press releases may also interest you

at 08:45
Cannabix Technologies Inc. (the "Company or Cannabix") developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC ("Friedel Clinic") a private monitoring agency, based in...

at 08:43
The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, announces that Purina has donated $111,910 in support of CHF-funded canine health research thanks to its Purina Parent...

at 08:41
eRSP, a trailblazer in innovative home health solutions, proudly reveals a new brand alongside a refreshed website. This step showcases eRSP's commitment to transformation, innovation and lays the groundwork for what the home health industry can...

at 08:35
Vistagen , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an...

at 08:34
Canopy Life Sciences ("Canopy"), a leading provider of clinical to commercial solutions to the life sciences industry, is delighted to announce the appointment of Susanne Clark as President. With over 25 years of experience in the life sciences...

at 08:34
Innovative Medical Products, Inc. (IMP) and Curexo Inc. are pleased to announce a global strategic distribution partnership combining Curexo's artificial joint surgical robot, CUVIS-joint, with IMP's industry-leading De Mayo D2® Knee Positioner....



News published on and distributed by: